Search images on Google Product Monograph
Active Ingredients:
- romosozumab, 105 MG/1.17 ML
DIN: 02489597
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: PREFILLED SYRINGE
Schedule: Prescription
Company: AMGEN CANADA INC
ATC:
- M05 - DRUGS FOR TREATMENT OF BONE DISEASES (ATC, WHO, Wiki)
- M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, WHO)
- M05BX - Other drugs affecting bone structure and mineralization (ATC, WHO)
- M05BX06 - ROMOSOZUMAB (WHO)